Roivant Sciences Ltd.(ROIV)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ROIV | 24.71 B | - | -33.50% | 0.00% | -$0.46 | -8.52% | 2.18x | 0.00% | $42.50 | $15.25 |
GNS.L | 152.81 B | 543.53x | -4.10% | 43.35% | $4.25 | 45.95% | 0.14x | 0.02% | $3219.87 | $1943.00 |
KNSA | 3.80 B | 78.75x | 55.40% | 9.59% | $1.00 | 14.04% | 1.36x | 0.00% | $82.94 | $35.20 |
CMPS | 1.59 B | - | - | 0.00% | -$3.64 | -319.07% | 0.65x | 0.00% | $15.87 | $4.88 |
CNTA | - | - | - | - | - | - | - | - | - | - |
Peer Valuation & Performance Analysis
Peer group analysis for Roivant Sciences Ltd. (ROIV) compared to its primary competitors (including GNS.L, KNSA, CMPS) reveals distinct metrics. ROIV trades at a valuation discount relative to its competitors, with a P/E ratio of -74.4x versus the peer average of 206.4x (representing a 136% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, ROIV's revenue growth of -33.5% lags behind the peer average of 25.7%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 0.0% is below the peer average of 17.6%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ROIV ranks #0 in P/E ratio, #3 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $34.27 | $34.56 | $33.32 | $34.21 | 6,403,900 | -1.55% |
| 2026-10-07 | $35.22 | $35.48 | $34.63 | $34.75 | 5,738,800 | -2.20% |
| 2026-10-06 | $35.86 | $36.34 | $34.75 | $35.53 | 5,737,700 | -0.70% |
| 2026-10-05 | $35.98 | $36.33 | $35.24 | $35.78 | 6,200,500 | +0.17% |
| 2026-10-02 | $35.61 | $36.00 | $35.19 | $35.72 | 4,365,800 | +0.62% |
| 2026-10-01 | $36.35 | $36.79 | $35.44 | $35.50 | 3,272,000 | -2.93% |
| 2026-09-30 | $36.77 | $36.95 | $36.23 | $36.57 | 5,282,400 | +0.19% |
| 2026-09-29 | $37.03 | $37.34 | $35.75 | $36.50 | 6,587,600 | -1.30% |
| 2026-09-28 | $35.65 | $37.24 | $35.28 | $36.98 | 6,970,800 | +3.30% |
| 2026-09-25 | $35.98 | $36.19 | $35.52 | $35.80 | 6,764,400 | -0.91% |
| 2026-09-24 | $36.64 | $36.75 | $35.91 | $36.13 | 5,659,500 | -1.87% |
| 2026-09-23 | $38.00 | $38.47 | $36.78 | $36.82 | 9,272,900 | -3.66% |
| 2026-09-22 | $38.73 | $39.17 | $38.11 | $38.22 | 6,752,500 | -1.97% |
| 2026-09-21 | $39.02 | $39.90 | $38.72 | $38.99 | 5,620,100 | -1.96% |
| 2026-09-18 | $40.11 | $40.71 | $39.72 | $39.77 | 32,196,300 | -0.53% |
Explore More Analysis for ROIV
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.